Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

EV to Operating Cash Flow

-8.86×

TTM · Retrieved:

LCTX logo

LCTX EV to Operating Cash Flow

Current (TTM)-8.86×
LCTX Quarterly EV/OCF (0.00× → -40.28×)
High-resolution chart · PNG

LCTX ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock EV to Operating Cash Flow — Quarterly
Period endingEV to Operating Cash Flow
-40.2799×
-43.7733×
-70.9147×
-96.4932×
-30.1667×
-11.5522×
-9.0328×
-25.2207×
-29.6514×
-39.2055×
-25.8702×
-35.3286×
-33.5119×
-21.649×
-23.0585×
-31.0048×
-28.0914×
8.4802×
-60.9124×
-75.1486×
-73.0724×
-43.15×
-41.6934×
-22.8471×
-28.8387×
-23.6881×
-23.2367×
-18.4888×
-15.5926×
-17.1575×
-16.2145×
-36.6826×
-31.828×
-30.2653×
-41.1118×
-40.6452×
-35.6579×
-42.9798×
-39.868×
-41.8745×
-21.3063×
-16.5947×
-23.9191×
-18.0369×
-25.7464×
-40.1307×
-28.7396×
-23.9246×
-15.955×
-17.8647×
-22.8429×
-31.8938×
-27.9238×
-26.3588×
-30.0914×
-40.7529×
-55.5528×
-34.9418×
-75.1356×
-52.68×
-79.8239×
-91.4074×
-129.0751×
-88.6391×
-123.2897×
-186.8974×
-152.89×
-117.3871×
-72.7272×
-55.6928×
-88.4827×
-96.2245×
-31.2606×
-29.2794×
-28.5965×
-49.8245×
-29.86×
-32.8503×
-29.1556×
-16.7482×
-44.1889×
-10.2883×
14.6827×
-11.3637×
-22.0585×
-29.5303×
-129.1627×
-96.9236×
-73.2145×
-35.8924×
-52.6319×
46.1009×
-179.9495×
-40.3098×
-42.7251×
-32.9739×
-54.3975×
-53.693×
-188.5905×
-60.7739×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.